Skip to main content

Abstract

Pocket hematoma is an acute, relatively common complication that may occur after totally implantable venous access device (TIVAD) with an incidence ranging between 0% and 4.5%. A hematoma is assumed to be present if there is any palpable swelling of the TIVAD pocket exceeding the size of the device. The causes of the port hematoma may be intraoperative or postoperative. Intraoperative causes may be the consequence of a defective technique. Postoperative causes may also be the pharmacological therapy. In the event of hematoma the use of the port should be delayed until resorption in order to avoid the risk of infection. In case of doubt, this complication should be sonographically confirmed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Pavia S, Wilkoff B (2001) The management of surgical complications of pacemaker and implantable cardioverter-defibrillators. Curr Opin Cardiol 16:66–71

    Article  PubMed  CAS  Google Scholar 

  2. Ku YH, Kuo PH, Tsai YF et al (2009) Port-a-cath implantation using percutaneous puncture without guidance. Ann Surg Oncol 16:729–734

    Article  PubMed  Google Scholar 

  3. Vardy J, Engelhardt K, Cox K et al (2004) Long-term outcome of radiological-guided insertion of implanted central venous access port devices (CVAPD) for the delivery of chemotherapy in cancer patients: institutional experience and review of the literature. Br J Cancer 91:1045–1049

    PubMed  CAS  Google Scholar 

  4. Di Carlo I, Pulvirenti E, Mannino M, Toro A (2010) Increased use of percutaneous technique for totally implantable venous access devices. Is it real progress? A 27-year comprehensive review on early complications. Ann Surg Oncol 17:1649–1656

    Article  PubMed  Google Scholar 

  5. Sakamoto N, Arai Y, Takeuchi Y et al (2010) Ultrasound-guided radiological placement of central venous port via the subclavian vein: a retrospective analysis of 500 cases at a single institute. Cardiovasc Intervent Radiol 33:989–994

    Article  Google Scholar 

  6. Kurul S, Saip P, Aydin T (2002) Totally implantable venous-access ports: local problems and extravasation injury. Lancet Oncol 3:684–691

    Article  PubMed  Google Scholar 

  7. Asch MR (2001) Venous access: options, approaches and issues. Can Assoc Radiol J 52:153–164

    PubMed  CAS  Google Scholar 

  8. Gray RR, Sadler DJ, Shulman L et al (1999) Should anticoagulant therapy be stopped or reversed before venous intervention? Can Assoc Radiol J 50:306–309

    PubMed  CAS  Google Scholar 

  9. Michaud GF, Pelosi FJ, Noble MD et al (2000) A randomized trial comparing heparin initiation 6h or 24 h after pacemaker or defibrillator implantation. J Am Coll Cardiol 35:1915–1918

    Article  PubMed  CAS  Google Scholar 

  10. Belott P, Reynolds D (2000) Permanent pacemaker and implantable cardioverter defibrillator implantation. In: Ellenboggen K, Kay G, Wilkoff B (eds) Clinical cardiac pacing and defibrillation. WB Saunders, Philadelphia, pp 573–644

    Google Scholar 

  11. Rouzrokh M, Shamsian BS, Tabari AKN et al (2009) Totally implantable subpectoral vs. subcutaneous port systems in children with malignant diseases. Arch Iranian Med 12:389–394

    Google Scholar 

  12. Knebel P, Fischer L, Cremonese E et al (2008) Protocol of an expertise based randomized trial comparing surgical venae section versus radiological puncture of vena subclavia for insertion of totally implantable access port in oncological patients. Trials 9:60

    Article  PubMed  Google Scholar 

  13. Poorter RL, Lauw FN, Bemelman WA et al (1996) Complications of an implantable venous access device (port a cath) during intermittent continuous infusion of chemotherapy. Eur J Cancer 32:2262–2266

    Article  Google Scholar 

  14. Wiegand UKH, LeJeune D, Boguschewski F et al (2004) Pocket haematoma after pacemaker or implantable cardioverter defibrillator surgery: influence of patient morbidity, operation strategy, and perioperative antiplatelet/anticoagulation therapy. Chest 126:1177–1186

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Isidoro Di Carlo .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag Italia

About this chapter

Cite this chapter

Toro, A., Di Carlo, I. (2012). Pocket Hematoma. In: Di Carlo, I., Biffi, R. (eds) Totally Implantable Venous Access Devices. Springer, Milano. https://doi.org/10.1007/978-88-470-2373-4_19

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-2373-4_19

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-2372-7

  • Online ISBN: 978-88-470-2373-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics